HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Weizhong Gu Selected Research

Biliary Atresia

4/2005Rotavirus-induced murine biliary atresia is mediated by nuclear factor-kappaB.
11/2004The aberrant expression of HLA-DR in intrahepatic bile ducts in patients with biliary atresia: an immunohistochemistry and immune electron microscopy study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Weizhong Gu Research Topics

Disease

11Infections
06/2023 - 04/2005
7Nephrotic Syndrome (Syndrome, Nephrotic)
11/2023 - 01/2015
6Proteinuria
05/2024 - 02/2015
6Neoplasms (Cancer)
03/2023 - 10/2014
4Inflammation (Inflammations)
06/2023 - 10/2018
2Neuroblastoma
12/2023 - 03/2023
2Lung Injury
06/2023 - 10/2018
2Fetal Growth Retardation (Intrauterine Growth Retardation)
02/2023 - 01/2019
2Pathologic Constriction (Stenosis)
01/2022 - 01/2020
2Fibrosis (Cirrhosis)
01/2022 - 01/2017
2Hematuria
01/2021 - 09/2016
2Ischemic Stroke
01/2019 - 10/2014
2Body Weight (Weight, Body)
10/2018 - 11/2007
2Vomiting
12/2015 - 07/2015
2Pulmonary Hypertension
11/2014 - 06/2005
2Biliary Atresia
04/2005 - 11/2004
1IGA Glomerulonephritis (IGA Nephropathy)
05/2024
1Dent Disease
12/2023
1Dent disease 1
12/2023
1Atrophy
11/2023
1Asthma (Bronchial Asthma)
02/2023
1Necrotizing Enterocolitis
01/2022
1Coinfection
01/2022
1Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
01/2022
1Lymphangioma (Cavernous Lymphangioma)
01/2022
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022
1Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
09/2021
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
09/2021
1Microphthalmos
01/2021
1Sinusitis
01/2021
1Chorioamnionitis
01/2021
1Arachnoid Cysts (Intracranial Arachnoid Cysts)
01/2021
1Brucellosis (Malta Fever)
01/2021
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/2021
1Glomerulonephritis
01/2021
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2021
1Stroke (Strokes)
01/2021
1Human Influenza (Influenza)
01/2021
1Wilms Tumor (Wilm's Tumor)
01/2021
1Mesoblastic Nephroma (Congenital Mesoblastic Nephroma)
10/2020
1Tuberous Sclerosis (Bourneville's Disease)
05/2020
1Glomus Tumor (Glomus Tumors)
05/2020

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2012
4SteroidsIBA
09/2016 - 01/2015
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2018 - 06/2005
2Adrenal Cortex Hormones (Corticosteroids)IBA
05/2024 - 01/2015
2Biomarkers (Surrogate Marker)IBA
12/2023 - 06/2023
2RNA (Ribonucleic Acid)IBA
12/2023 - 01/2021
2Messenger RNA (mRNA)IBA
12/2023 - 07/2015
2GlucocorticoidsIBA
11/2023 - 01/2022
2Indicators and Reagents (Reagents)IBA
03/2023 - 01/2015
2Antigen-Antibody Complex (Immune Complex)IBA
01/2022 - 01/2021
2Peroxidase (Myeloperoxidase)IBA
01/2022 - 01/2021
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2022 - 01/2021
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2022 - 06/2005
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 10/2018
2Therapeutic UsesIBA
01/2021 - 11/2007
2OccludinIBA
01/2021 - 07/2015
2Viral AntigensIBA
01/2021 - 04/2005
2CateninsIBA
11/2019 - 07/2015
2Insulin (Novolin)FDA Link
11/2019 - 01/2012
22',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)IBA
01/2019 - 03/2012
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
05/2024
1ChloridesIBA
12/2023
1Telomerase (Telomerase Reverse Transcriptase)IBA
12/2023
1ParaffinIBA
12/2023
1Formaldehyde (Formol)FDA Link
12/2023
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2023
1SuspensionsIBA
06/2023
1Long Noncoding RNAIBA
06/2023
1UbiquitinIBA
02/2023
1EnzymesIBA
02/2023
1OvalbuminIBA
02/2023
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2022
1Sirtuin 1IBA
01/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022
1Myeloblastin (Proteinase 3)IBA
01/2022
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2022
1Interleukin-10 (Interleukin 10)IBA
01/2022
1Immunoglobulin A (IgA)IBA
01/2022
1AutoantibodiesIBA
09/2021
1Annexin A2 (Annexin II)IBA
09/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Gold Colloid (Colloidal Gold)IBA
01/2021
1CarrageenanIBA
01/2021
1Claudin-1IBA
01/2021
1Immunologic Factors (Immunomodulators)IBA
01/2021
1Thymidine Monophosphate (TMP)IBA
01/2021
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2021
1Rifampin (Rifampicin)FDA LinkGeneric
01/2021
1enhanced green fluorescent proteinIBA
01/2021
1Nuclear Proteins (Protein, Nuclear)IBA
01/2021
1OligosaccharidesIBA
01/2021
1Phosphotransferases (Kinase)IBA
10/2020
1RolipramIBA
07/2020
1trans-sodium crocetinate (crocetin)IBA
05/2020

Therapy/Procedure

7Therapeutics
11/2023 - 04/2014
2Drug Therapy (Chemotherapy)
03/2023 - 04/2014
2Surgical Portasystemic Shunt (Portosystemic Shunt)
01/2022 - 01/2021
1Nephrectomy
01/2021